Cargando…
Proteomic Biomarkers for the Detection of Endometrial Cancer
Endometrial cancer is the leading gynaecological malignancy in the western world and its incidence is rising in tandem with the global epidemic of obesity. Early diagnosis is key to improving survival, which at 5 years is less than 20% in advanced disease and over 90% in early-stage disease. As yet,...
Autores principales: | Njoku, Kelechi, Chiasserini, Davide, Whetton, Anthony D., Crosbie, Emma J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826703/ https://www.ncbi.nlm.nih.gov/pubmed/31623106 http://dx.doi.org/10.3390/cancers11101572 |
Ejemplares similares
-
Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2020) -
Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2020) -
Comprehensive Library Generation for Identification and Quantification of Endometrial Cancer Protein Biomarkers in Cervico-Vaginal Fluid
por: Njoku, Kelechi, et al.
Publicado: (2021) -
Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women
por: Njoku, Kelechi, et al.
Publicado: (2023) -
Metabolomic Biomarkers for the Detection of Obesity-Driven Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2021)